Trial Profile
Rifaximin in patients with functional dyspepsia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2013
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Dyspepsia
- Focus Therapeutic Use
- 03 Jul 2013 New trial record
- 18 May 2013 Results presented at the Digestive Disease Week 2013.